Since the advent of Covid-19 there has been an explosion in sanitisers, surface coverings and antimicrobial compounds aiming to combat the spread of coronavirus. And with the world on a mission to return to normal, the importance of high-quality health and hygiene, has never been more important. But the pandemic has rapidly highlighted that a new generation of health and hygiene infrastructure is required in order to keep up with modern life while maintaining high levels of cleanliness in our daily routines.

While restrictions are easing in many parts of the world, caution is still advised and leaders across multiple industries are making significant efforts to protect their staff and customers by preventing infection risks, especially in high-contact areas. A large part of this process requires access to state-of-the-art solutions which provide new ways to solve lasting challenges.

As innovative technologies are developed within the health and hygiene sector, they are being further supported by enhanced routines for individuals, organisations, and communities to implement on a daily basis. It is through this combination of innovative technologies and enhanced health and hygiene routines that effective ways to maintain a gold standard can be built.

Health and hygiene innovators

While preventing infections is extremely important across all sectors, areas such as healthcare require even more stringent measures. The world has experienced the consequences of failure to prevent infections and the rush to prevent additional waves has seen rapid advancements in anti-microbial coatings.

Enter BioInteractions. The healthcare innovators based to the west of London are at the forefront of antimicrobial technology and leading the charge when it comes to health and hygiene solutions that work to combat infection transmission across surfaces.

Host to state-of-the-art production and R&D facilities that are built around a specialist team, BioInteractions core business revolves around its expertise in medical device coatings, with its state-of-the-art antimicrobial coatings that kill bacteria, viruses, and other germs whilst reducing the threat of infection or rejection when devices are implanted.

Innovations in antimicrobial materials for medical devices has enabled the company to provide reliable and effective solutions to prevent infections and improve the cleanliness and hygiene of procedures on areas ranging from your skin to class three medical devices. Now for the first time ever, they have used human touch to help to disinfect rather than contaminate on touch. This offers a way to keep people protected once they stop washing with soap and water.

“With TridAnt® Skin Protection and an improved washing routine we can keep germs off your skin even as you shake hands,” says Arjun Luthra, BioInteractions commercial director. “Not only does TridAnt Skin Protection kill 99.99% of bacteria and viruses for up to 60 days on surfaces, but it also maintains this protection for up to 48 hours on your skin in varying conditions.

“The enhanced skin protection begins working when you stop washing. This is done through a new hand wash routine which will benefit all individuals, organisations and communities in bringing forward the better normal.”

Unrivalled antimicrobial protection on medical devices

TridAnt® medical technology is the company’s latest coating offering for medical devices. The product’s infection prevention infrastructure utilises expertise and technology from the medical device industry to provide consistent 99.999% killing against both gram-negative and gram-positive bacteria as well as yeast for up to 100 days.

In fact, TridAnt® medical technology is the only material which provides this level of antimicrobial efficacy for this duration on medical devices. This advancement will significantly help the healthcare industry to prevent infections, confront transmission of pathogens from one to another and tackle antimicrobial resistance.

TridAnt® utilises the benefits of BioInteractions’ broad portfolio of non-leaching biocompatible coatings, to provide enhanced infection resistance for extensive periods of time. The coating targets a broad spectrum of bacteria, and causing them to physically lyse preventing the risk of infections on medical devices. This is all achieved without the use of toxic or eluting components. Thereby making this a critical improvement to antimicrobial technology on medical devices.

To find out more, download the whitepaper below.